Lonza stock eases as RaMP launches and 2026 EPS stays at CHF 18.14
Published on 08/24/2026 at 16:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Lonza Group (CH0013841017) shares fell 0.4% to CHF 590.00 at 09:28 a.m. on August 24, 2026, while 4,700 shares changed hands and the 52-week high from August 21, 2026 stood at CHF 594.00. The move came as Lonza added a new Rapid Media Prototyping Service for early bioprocess development, a product step that keeps the market's attention on the company's CDMO portfolio.
New service, same execution test
The launch, reported on August 18, 2026, says the service gives biopharmaceutical companies faster access to custom liquid and powder media for screening, process confirmation and early development. It also says non-GMP powder batches can range from 1 to 10 kg and liquid batches from 1 to 100 L, with production within 10 working days.
For investors, the key comparison is that the share price was still CHF 4.00 below the August 21, 2026 peak even after the service announcement. That leaves the near-term debate tied less to product language and more to whether Lonza can turn launch cadence into order flow and margin support.
Consensus stays firm
Current earnings expectations point to EPS of CHF 18.14 for 2026, with one market report also noting a projected dividend of CHF 5.59 for the year after CHF 5.00 was paid in 2025. Those figures give the stock a concrete earnings and payout frame for the rest of 2026.
The same market report also put the SMI at 14,416 points at the time of the Lonza move, which shows the shares were trading inside a broader Swiss large-cap index that was already being watched closely by local investors. The result is a cleaner setup than a pure headline trade: the stock is lower, but the company is still being measured against guidance, cash returns and the pace of launch execution.
RaMP and the CDMO model
RaMP fits Lonza's broader contract development and manufacturing model by linking early formulation work with later GMP manufacturing. The service is aimed at cutting time between design and process decisions, which matters in a business where speed, scale and reproducibility shape customer retention.
Price level at 09:28
Lonza shares traded at CHF 590.00 at 09:28 a.m. on August 24, 2026, after opening at CHF 591.20 and touching CHF 589.60. The 52-week low stood at CHF 454.60 on March 23, 2026.
Fact box
Company: Lonza Group AG
ISIN: CH0013841017
Ticker: LONN
Exchange: SIX Swiss Exchange
Price (as of August 24, 2026, 09:28 a.m. ET): CHF 590.00
Market cap: CHF 42.2 billion
Sector / Industry: Health Care / Life Sciences Tools & Services
Index membership: SMI
Next earnings date: January 27, 2027
